§ Same category · GLP-1 / metabolic peptides
Survodutide vs Tesofensine
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Survodutide
0
vendors tracked
Tesofensine
0
vendors tracked
Survodutide
Glucagon/GLP-1 dual agonist
No current listings at 10mg.
Tesofensine
Triple monoamine reuptake inhibitor
No current listings at 1mg.
About Survodutide
A dual glucagon/GLP-1 receptor agonist in clinical trials for obesity and MASH. Research-compound version sold as the free acid.
About Tesofensine
A serotonin-noradrenaline-dopamine reuptake inhibitor studied for obesity. Approved for obesity in Mexico; investigational elsewhere.